| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Exerts Antitumor Effects in Cholangiocarcinoma AXL/STAT3 Inactivation and Rho GTPase Down-regulation. | Khamko, R Daduang, J Settasatian, C Limpaiboon, T |
2021 | ||||
| 2. | OPCML Exerts Antitumor Effects in Cholangiocarcinoma via AXL/STAT3 Inactivation and Rho GTPase Down-regulation | Ricuphan Khamko Jureerut Daduang Chatri Settasatian Temduang Limpaiboon |
2021 | ||||
| 3. | Combined OPCML and AXL Expression as a Prognostic Marker and OPCML Enhances AXL Inhibitor in Cholangiocarcinoma | Khamko, R Wasenang, W Daduang, J Settasatian, C Limpaiboon, T |
2022 | Count | 2 | 2 | 1 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | ||||||
| 1. | OPCML Exerts Antitumor Effects in Cholangiocarcinoma via AXL/STAT3 Inactivation and Rho GTPase Down-regulation | Daduang, J. Settasatian, C. Limpaiboon, T. |
2021 |
Cancer genomics & proteomics 6 (18), pp. 771-780 |
||||||||
| 2. | Combined OPCML and AXL Expression as a Prognostic Marker and OPCML Enhances AXL Inhibitor in Cholangiocarcinoma | Daduang, J. Settasatian, C. Limpaiboon, T. |
2022 |
In Vivo 3 (36), pp. 1168-1177 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Exerts Antitumor Effects in Cholangiocarcinoma AXL/STAT3 Inactivation and Rho GTPase Down-regulation. | Khamko, R Daduang, J Settasatian, C Limpaiboon, T |
2021 |
Cancer genomics & proteomics 6 (18), pp. 771-780 |
|
| 2. | Combined OPCML and AXL Expression as a Prognostic Marker and OPCML Enhances AXL Inhibitor in Cholangiocarcinoma. | Khamko, R Wasenang, W Daduang, J Settasatian, C Limpaiboon, T |
2022 |
In vivo (Athens, Greece) 3 (36), pp. 1168-1177 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | ||||||
| 1. | OPCML Exerts Antitumor Effects in Cholangiocarcinoma via AXL/STAT3 Inactivation and Rho GTPase Down-regulation | Ricuphan Khamko Jureerut Daduang Chatri Settasatian Temduang Limpaiboon |
2021 |
CANCER GENOMICS & PROTEOMICS 6.0 (18.0), pp. 771.0-780.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|